BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31793624)

  • 1. Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study.
    Wang X; Xie J; Pang J; Zhang H; Chen X; Lin J; Li Q; Chen Q; Ma J; Xu X; Yang Y; Ling W; Chen Y
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31793624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women: A Cross-Sectional Study.
    Wang N; Zhai H; Zhu C; Li Q; Han B; Chen Y; Zhu C; Chen Y; Xia F; Lin D; Lu Y
    Medicine (Baltimore); 2016 Jan; 95(4):e2621. PubMed ID: 26825918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M; VanWagner LB; Terry JG; Carr JJ; Rinella M; Schreiner PJ; Lewis CE; Terrault N;
    Am J Gastroenterol; 2019 May; 114(5):758-763. PubMed ID: 30730350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.
    Jaruvongvanich V; Sanguankeo A; Riangwiwat T; Upala S
    Ann Hepatol; 2017; 16(3):382-394. PubMed ID: 28425408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients.
    Hua X; Sun Y; Zhong Y; Feng W; Huang H; Wang W; Zhang T; Hu Y
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):877-83. PubMed ID: 24303796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men.
    Fujihara Y; Hamanoue N; Yano H; Tanabe M; Akehi Y; Nomiyama T; Yanase T
    Endocr J; 2019 Jul; 66(7):637-645. PubMed ID: 31068503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients.
    Hua X; Li M; Pan F; Xiao Y; Cui W; Hu Y
    Sci Rep; 2017 Nov; 7(1):14532. PubMed ID: 29109457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease.
    Ye J; Yao Z; Tan A; Gao Y; Chen Y; Lin X; He R; Tang R; Hu Y; Zhang H; Yang X; Wang Q; Jiang Y; Mo Z
    Horm Metab Res; 2017 May; 49(5):359-364. PubMed ID: 28282659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
    Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
    World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study.
    Gu Y; Luo J; Chen Q; Qiu Y; Zhou Y; Wang X; Qian X; Liu Y; Xie J; Xu Z; Ling W; Chen Y; Yang L
    Ann Nutr Metab; 2022; 78(1):21-32. PubMed ID: 34814152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between serum sex hormone-binding globulin and non-alcoholic steatohepatitis].
    Zhao XY; Gu TW; Fang D; Sun HX; Bi Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1239-1246. PubMed ID: 36323566
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults.
    Luo J; Chen Q; Shen T; Wang X; Fang W; Wu X; Yuan Z; Chen G; Ling W; Chen Y
    Nutr Metab (Lond); 2018; 15():79. PubMed ID: 30455723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development.
    Saez-Lopez C; Barbosa-Desongles A; Hernandez C; Dyer RA; Innis SM; Simó R; Selva DM
    Endocrinology; 2017 Mar; 158(3):545-559. PubMed ID: 28359088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.
    Wang X; Chen X; Zhang H; Pang J; Lin J; Xu X; Yang L; Ma J; Ling W; Chen Y
    Diabetes Metab; 2020 Apr; 46(2):119-128. PubMed ID: 31078721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men.
    Price JC; Wang R; Seaberg EC; Brown TT; Budoff MJ; Kingsley LA; Palella FJ; Witt MD; Post WS; Lake JE; Thio CL
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz468. PubMed ID: 32128321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study.
    Liu F; Zhou H; Cao L; Guo Z; Dong C; Yu L; Wang Y; Liu C; Qiu J; Xue Y; Liu X; Xu Y
    Lipids Health Dis; 2018 Sep; 17(1):221. PubMed ID: 30227874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity.
    Wang R; Yang F; Qing L; Huang R; Liu Q; Li X
    Clin Obes; 2019 Feb; 9(1):e12289. PubMed ID: 30411515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.